Goldman Sachs
INSP icon

Goldman Sachs’s Inspire Medical Systems INSP Stock Holding History

Goldman Sachs’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,200
Closed -$253K – 6150
2024
Q3 		$253K Buy
+1,200
New +$208K ﹤0.01% 5373
2024
Q2 		– Sell
-1,200
Closed -$258K – 5784
2024
Q1 		$258K Hold
1,200
– – ﹤0.01% 5028
2023
Q4 		$244K Buy
+1,200
New +$194K ﹤0.01% 5079
2020
Q4 		– Sell
-32,100
Closed -$4.14M – 5587
2020
Q3 		$4.14M Buy
+32,100
New +$3.54M ﹤0.01% 3047

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs's INSP Position: Q2 2026 in Review

Goldman Sachs reduced its Inspire Medical Systems (INSP) stake by 2.7% in Q2 2026, selling an estimated $861K and leaving 645,858 shares worth $28.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

Goldman Sachs first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $62.6M in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Goldman Sachs held 645,858 shares of Inspire Medical Systems worth $28.8M as of Q2 2026.
  • Goldman Sachs sold 18,145 Inspire Medical Systems shares in Q2 2026, an estimated $861K.
  • Inspire Medical Systems made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2306 holding.
  • Goldman Sachs first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
  • Goldman Sachs's Inspire Medical Systems position peaked at $62.6M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.